- Home
- FBRX
as 12-20-2024 4:00pm EST
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 8.3M | IPO Year: | N/A |
| Target Price: | $77.58 | AVG Volume (30 days): | 140.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -18.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.11 - $28.68 | Next Earning Date: | 11-14-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Forte Biosciences Inc. (FBRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Riley Antony A | FBRX | CHIEF FINANCIAL OFFICER | Nov 21 '24 | Buy | $5.55 | 22,514 | $124,997.73 | 30,776 |
Latest Forte Biosciences Inc. News
FBRX Breaking Stock News: Dive into FBRX Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Forte Biosciences to Host R&D Day December 3, 2024
Business Wire
a month ago
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Business Wire
a month ago
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
TipRanks
4 months ago
Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested
Business Wire
4 months ago
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
Newsfile
6 months ago
Edge Total Intelligence Inc. Updates Status of MCTO
CNW Group
6 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
GlobeNewswire
6 months ago
The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
Compare FBRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FBRX Forte Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.